GlassScriptPhysician profile
Aaron A Ambrad
NPI 1265411961
$18,038.65
in general payments reported to CMS, 2019-2025
82 companies · $4,136 in 2025
The $4,136 reported for 2025 was more than what 94% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,170 · 2020: $590 · 2021: $3,920 · 2022: $2,591 · 2023: $2,320 · 2024: $3,311 · 2025: $4,136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,759 · Education: $8.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,759.46 |
| Education | $8.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,884.59 | 2019-2025 | Imfinzi, Tagrisso |
| Novartis Pharmaceuticals Corporation | $1,365.28 | 2019-2025 | |
| Janssen Biotech, INC. | $999.24 | 2019-2025 | Tecvayli, Darzalex, Talvey |
| Merck Sharp & Dohme LLC | $942.71 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Novocure INC. | $703.82 | 2019-2025 | Optune Gio, Optune Lua (Novottf-200t), Optune |
| Pfizer INC. | $643.93 | 2019-2025 | |
| Genzyme Corporation | $633.02 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $565.43 | 2020-2025 | |
| Amgen INC. | $560.32 | 2019-2023 | Kyprolis, Nplate, Vectibix |
| Genentech USA, INC. | $436.76 | 2019-2025 | Tecentriq, Alecensa, Gavreto |
| Eisai INC. | $403.31 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $381.16 | 2019-2025 | Opdualag, Opdivo, Reblozyl |
| Seagen INC. | $371.30 | 2019-2023 | Tukysa, Padcev |
| Incyte Corporation | $338.98 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Abbvie INC. | $306.63 | 2022-2025 |
Show all 82 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $302.48 | 2019-2025 | Xtandi, Vyloy, Padcev |
| Lilly USA, LLC | $301.09 | 2020-2025 | Verzenio, Jaypirca, Retevmo |
| Celgene Corporation | $293.32 | 2021-2025 | Reblozyl |
| Daiichi Sankyo INC. | $292.46 | 2019-2025 | Enhertu, Datroway, Vanflyta |
| Tersera Therapeutics LLC | $271.33 | 2022-2025 | Zoladex |
| Pharmacyclics LLC, An Abbvie Company | $267.22 | 2021-2023 | Imbruvica, Epkinly |
| Emd Serono, INC. | $259.81 | 2019-2025 | Tepmetko, Bavencio |
| Takeda Pharmaceuticals U.S.A., INC. | $248.76 | 2021-2025 | Fruzaqla, Iclusig, Ninlaro |
| Exelixis INC. | $213.40 | 2021-2025 | Cabometyx |
| Blueprint Medicines Corporation | $210.33 | 2020-2025 | Ayvakit |
| Endomagnetics LTD | $195.75 | 2023 | Magseed, Magtrace |
| Stemline Therapeutics INC. | $189.43 | 2024-2025 | Orserdu |
| Gilead Sciences, INC. | $177.93 | 2022-2025 | Trodelvy |
| Caris Mpi, INC. | $164.31 | 2025 | Mi Cancer Seek |
| Aveo Pharmaceuticals, INC. | $156.84 | 2022-2025 | Fotivda |
| Glaxosmithkline, LLC. | $156.71 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Visionrt, INC. | $154.92 | 2024-2025 | |
| Kyowa Kirin, INC. | $147.72 | 2019-2024 | Poteligeo |
| Genmab U.S., INC. | $144.90 | 2023-2025 | Epkinly, Tivdak |
| Ipsen Biopharmaceuticals, INC | $136.93 | 2021-2024 | Somatuline Depot, Onivyde |
| Elekta, INC. | $125.17 | 2021 | |
| Progenics Pharmaceuticals, INC. | $111.06 | 2023-2024 | Pylarify |
| Regeneron Healthcare Solutions, INC. | $110.34 | 2021-2025 | Libtayo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.58 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $108.36 | 2021-2025 | |
| Karyopharm Therapeutics INC. | $94.91 | 2021-2024 | Xpovio |
| Lexicon Pharmaceuticals, INC. | $88.80 | 2019 | |
| Janssen Scientific Affairs, LLC | $83.50 | 2025 | Erleada, Akeega, Balversa |
| Puma Biotechnology, INC. | $82.96 | 2019-2024 | |
| Carbofix Orthopedics INC | $80.16 | 2025 | |
| Deciphera Pharmaceuticals INC. | $79.47 | 2024-2025 | Qinlock, Romvimza |
| Springworks Therapeutics, INC. | $76.79 | 2024-2025 | Ogsiveo |
| Alexion Pharmaceuticals, INC. | $68.91 | 2022-2024 | Ultomiris |
| Sun Pharmaceutical Industries INC. | $66.12 | 2019-2025 | Yonsa, Odomzo |
| Geron Corporation | $57.87 | 2025 | Rytelo |
| Iovance Biotherapeutics, INC. | $57.50 | 2025 | Amtagvi |
| Morphosys, US INC. | $53.07 | 2021-2023 | Monjuvi |
| Agios Pharmaceuticals, INC. | $50.34 | 2019-2023 | Pyrukynd |
| Clovis Oncology, INC. | $49.34 | 2020-2021 | |
| Adaptive Biotechnologies Corporation | $44.24 | 2022 | |
| Myovant Sciences INC. | $40.18 | 2021 | |
| Pharmaessentia USA Corporation | $37.64 | 2025 | Besremi |
| Tesaro, INC. | $37.14 | 2019 | |
| Mylan Institutional INC. | $32.61 | 2019 | |
| Catalyst Pharmaceuticals, INC. | $28.93 | 2023 | Firdapse |
| Rigel Pharmaceuticals, INC. | $27.35 | 2024 | Rezlidhia, Tavalisse |
| Acrotech Biopharma INC. | $25.68 | 2025 | Beleodaq |
| Macrogenics, INC. | $24.90 | 2022 | |
| Eusa Pharma (US) LLC | $24.75 | 2022 | |
| Azurity Pharmaceuticals, INC. | $24.00 | 2025 | Danziten |
| Recordati_rare_diseases_inc. | $23.53 | 2025 | Enjaymo |
| Alnylam Pharmaceuticals INC. | $23.42 | 2023 | Givlaari |
| Verastem, INC. | $23.12 | 2019-2020 | |
| Adc Therapeutics America, INC. | $22.61 | 2025 | |
| Janssen Pharmaceuticals, INC | $22.52 | 2024 | Xarelto |
| Cti Biopharma Corp. | $22.47 | 2022 | |
| Amneal Pharmaceuticals LLC | $19.64 | 2025 | Alymsys |
| Tolmar, INC. | $19.28 | 2025 | Eligard, Rubraca |
| Pharmaand Gmbh | $19.28 | 2025 | Rubraca |
| Pharmacosmos Therapeutics INC. | $18.96 | 2025 | Monoferric |
| Shire North American Group INC | $18.02 | 2019 | |
| Fennec Pharmaceuticals, INC. | $15.69 | 2025 | Fyarro |
| Coherus Oncology, INC. | $15.30 | 2021 | |
| Apellis Pharmaceuticals, INC. | $14.07 | 2022 | |
| Aurobindo Pharma USA, INC. | $13.46 | 2020 | |
| Helsinn Therapeutics (U.S.), INC. | $12.18 | 2022 | |
| Dova Pharmaceuticals | $11.31 | 2021 |
Drugs and devices associated with these payments
Keytruda $618Imbruvica $356Xofigo $317Lenvima $297Xtandi $297Epkinly $276Nubeqa $265Optune Gio $259Zoladex $227Imfinzi $220Lynparza $199Verzenio $197Kisqali $196Magtrace $196Magseed $196Orserdu $189Orgovyx $189Reblozyl $182Tecentriq $176Jakafi $174Optune Lua (Novottf-200t) $169Mi Cancer Seek $164Alecensa $163Gavreto $163Stivarga $162Vitrakvi $162Ayvakit $162Cabometyx $159Talzenna $148Polivy $147Welireg $147Tecvayli $141Darzalex $140Tukysa $133Monjuvi $131Erleada $124Elrexfio $117Optune $114Fabhalta $112Enhertu $111Pylarify $111Perjeta $106Phesgo $106Ibrance $101Padcev $96.57Poteligeo $95.09Piqray $92.41Trodelvy $91.53Rozlytrek $90.14Tagrisso $87.50Zepzelca $86.13Talvey $83.51Akeega $83.50Balversa $83.50Jaypirca $80.44Qinlock $79.47Fotivda $78.61Pemazyre $73.56Lunsumio $73.04Columvi $73.04Opdualag $71.83Scemblix $71.78Jevtana $71.40Jemperli $63.05Tivdak $60.12Datroway $59.60Libtayo $59.26Rytelo $57.87Amtagvi $57.50Retevmo $53.45Fruzaqla $53.34Zejula $51.48Ultomiris $49.89Lutathera $48.43Pluvicto $47.49Iclusig $46.00Kyprolis $45.44Enjaymo $44.50Ogsiveo $44.20Rybrevant $44.14Vyloy $44.10Ninlaro $40.57Bosulif $40.51Opdivo $40.19Zynyz $39.44Rubraca $38.56Alunbrig $38.52Odomzo $38.35Yonsa $38.35Besremi $37.64Comirnaty $37.41Paxlovid $37.41Xgeva $35.12Nplate $35.12Vectibix $35.12Tepmetko $32.35Ojjaara $30.72Romvimza $30.64Vanflyta $29.55Wayrilz $29.38
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Ambrad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.